Philip Paterno
Surgical · Staten Island, NYNPI 1558334128
Payments from drug & device makers
Across 127 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$355
- Tolmar, Inc.$328
- Astellas Pharma US Inc$251
- AbbVie$227
- Urovant Sciences Inc$118
- Sumitomo Pharma America, Inc.$83
- plus $876 from 25 others
What the payments were for
- Food & beverage$2,237100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 23 | $355 |
| Tolmar, Inc. | 17 | $328 |
| Astellas Pharma US Inc | 18 | $251 |
| AbbVie | 7 | $227 |
| Urovant Sciences Inc | 6 | $118 |
| Sumitomo Pharma America, Inc. | 4 | $83 |
| Amgen | 4 | $77 |
| Bayer | 5 | $74 |
| Progenics Pharmaceuticals, Inc. | 3 | $69 |
| Merck | 4 | $66 |
| 180 Medical, Inc. | 4 | $65 |
| Boston Scientific | 3 | $62 |
| Myovant Sciences Inc. | 4 | $61 |
| Immunitybio, Inc. | 3 | $45 |
| Civco Medical Instruments | 2 | $42 |
| Tolmar Pharmaceuticals, Inc. | 2 | $30 |
| Verity Pharmaceuticals Inc. | 2 | $30 |
| Endo Pharmaceuticals Inc. | 2 | $27 |
| Dendreon Pharmaceuticals LLC | 2 | $27 |
| Palette Life Sciences, Inc. | 1 | $21 |
| Accord Healthcare, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Endo USA, Inc. | 1 | $19 |
| Teleflex LLC | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Procept Biorobotics Corporation | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Bioprotect Medical, Inc. | 1 | $14 |
| Mission Pharmacal Company | 1 | $14 |
| ABC Home Medical Supply, Inc. | 1 | $14 |
| Photocure Inc | 1 | $13 |
How this compares
$2,237 in reported general payments places this provider in the 85th percentile of 1,544 surgical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 65 | $36,060 |
| GemtesaVibegron | 12 | $14,022 |
| Tamsulosin Hcl | 370 | $6,024 |
| Dutasteride | 82 | $4,119 |
| Trospium Chloride ErTrospium Chloride | 37 | $4,004 |
| Silodosin | 31 | $3,642 |
| Solifenacin Succinate | 20 | $2,608 |
| Cefpodoxime Proxetil | 72 | $2,449 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 68 | $2,023 |
| Finasteride | 102 | $1,475 |
| Oxybutynin Chloride ErOxybutynin Chloride | 47 | $1,471 |
| Trospium Chloride | 16 | $915 |
| Methenamine Hippurate | 11 | $403 |
| Levofloxacin | 43 | $105 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $101 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $251 | $36,06065 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $83 | $14,02212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,544 surgical providers in New York.
Other surgical in Staten Island
- Lindsay SchweikarthAlbany$324K
- Nicole FeinNew York$225K
- Kenneth RuizNew York$93K
- Sarah MartineckWilliamsville$87K
- Terry LinNew York$70K
- Beth PhillipsEast Syracuse$51K
- James DoolittleNew York$46K
- Tanya GeistAmherst$43K
- Irina KommNew York$39K
- Alexandra DemeglioNew York$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.